Amneal Pharmaceuticals (AMRX) EBIT Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) reported EBIT Margin of 16.30% for Q2 2026, up 0.93 percentage points from 15.37% a year earlier but down 3.32 percentage points from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBIT Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Amneal Pharmaceuticals' EBIT Margin came in at 14.56%, up 1.37 percentage points year-over-year; for FY2025, it was 13.05%, up 4.13 percentage points from FY2024.
- EBIT Margin has increased for three consecutive years, with a five-year change of +8.48 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at 8.92% in FY2024 (+0.39 pp), 8.54% in FY2023 (+12.83 pp), -4.29% in FY2022 (-11.59 pp) and 7.29% in FY2021 (+2.72 pp).
- Five-year quarterly EBIT Margin spans a low of -35.51% in Q2 2022 and a high of 19.62% in Q1 2026.
- Year over year, EBIT Margin has now increased in each of the last three quarters, with an average year-over-year change of +4.02 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q2 2023 (a gain of 48.88 percentage points); the low point was Q2 2022 (a drop of 48.05 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 19.62% (Q1 2026), 13.76% (Q4 2025) and 8.97% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Amneal Pharmaceuticals | 6.45 Bn | 5.73 Bn | 334.51 Mn | 16.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.30% |
| Mar 31, 2026 | 19.62% |
| Dec 31, 2025 | 13.76% |
| Sep 30, 2025 | 8.97% |
| Jun 30, 2025 | 15.37% |
| Mar 31, 2025 | 14.43% |
| Dec 31, 2024 | 10.38% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | 13.60% |
| Mar 31, 2024 | -1.63% |
| Dec 31, 2023 | 2.30% |
| Sep 30, 2023 | 12.20% |
| Jun 30, 2023 | 13.37% |
| Mar 31, 2023 | 6.18% |
| Dec 31, 2022 | 5.91% |
| Sep 30, 2022 | 8.13% |
| Jun 30, 2022 | -35.51% |
| Mar 31, 2022 | 4.68% |
| Dec 31, 2021 | 2.08% |
| Sep 30, 2021 | 5.39% |
API Access
Amneal Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();